Incidence and treatment of pulmonary embolism in patients with lung cancer. The experience of a tertiary hospital

Postgraduate Thesis uoadl:3217832 71 Read counter

Unit:
Κατεύθυνση Καρκίνος Πνεύμονα: Σύγχρονη Κλινικοεργαστηριακή Προσέγγιση και Έρευνα
Library of the School of Health Sciences
Deposit date:
2022-05-18
Year:
2022
Author:
Palavra Maria
Supervisors info:
Μπακάκος Πέτρος, Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Ροβίνα Νικολέττα, Επίκουρη Καθηγήτρια, Ιατρική Σχολή, ΕΚΠΑ
Συρίγος Κωνσταντίνος, Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Original Title:
Επίπτωση και θεραπεία της πνευμονικής εμβολής σε ασθενείς με καρκίνο πνεύμονα. Η εμπειρία ενός τριτοβάθμιου νοσοκομείου
Languages:
Greek
Translated title:
Incidence and treatment of pulmonary embolism in patients with lung cancer. The experience of a tertiary hospital
Summary:
Lung cancer is the most frequently diagnosed cancer and at the same time the leading cause of cancer deaths worldwide.
It is also an important risk factor for the development of pulmonary embolism in these patients.
Lung cancer and pulmonary embolism are two clinical entities coexisting, with the presence of pulmonary embolism affecting in a certain way the survival time of lung cancer patients.
265 patients with lung cancer, men or women, were eligible for this study. Incidences of pulmonary embolism in oncologic hospitalized patients at a tertiary hospital. The incidence of pulmonary embolism in lung cancer based on different studies is around 3,6%, close to the results of our current study.
Some of the most notable risk factors for the presence of pulmonary embolism is the advanced stage of the disease and the histological type of lung cancer, with NSCLC and in particular adenocarcinoma being the most common.
The lung cancer patients that are subjected to non - surgical treatments such as chemotherapy are more prone to pulmonary embolism than patients undergoing surgical treatment.
As for the therapeutic management of pulmonary embolism, anticoagulants and more specific LMWH is the gold standard medicine for treatment both during hospitalization and as outpatients, for a period of time three to six ( 3-6 ) months depending on every patient’s special characteristics and with constant observation and monitoring.
Main subject category:
Health Sciences
Keywords:
Lung cancer, Pulmonary embolism
Index:
No
Number of index pages:
0
Contains images:
Yes
Number of references:
56
Number of pages:
68
File:
File access is restricted only to the intranet of UoA.

palavramariadiplomatikh 1.pdf
2 MB
File access is restricted only to the intranet of UoA.